Clinical Trials
45 trialsFG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma
FluoGuide A/S
Peds IMPACT
University of Florida
EViDENCE-BT
University of Zurich
A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
University of Alabama at Birmingham
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
University of Iowa
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
NF118
University of Alabama at Birmingham
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Nationwide Children's Hospital
A Study for Cerebral Open Flow Microperfusion
Mayo Clinic
Language Network Prehab Via fMRI Neurofeedback
Yale University
APIC-RG
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
VANGUARD
Huashan Hospital
Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)
Azienda Sanitaria dell'Alto Adige
INSIGHT MRL
NYU Langone Health
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
Case Comprehensive Cancer Center
PRC
The Cooper Health System
NEURO-PRO-GLIO
Assistance Publique - Hôpitaux de Paris
DETERMINE
Cancer Research UK
Phase I Trial of pH Resections of GBM at VA
VA Office of Research and Development
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
University of California, San Francisco
BrainUS-AI
Hospital del Rio Hortega
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Neonc Technologies, Inc.
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
Medical College of Wisconsin
GABRIEL
Medical College of Wisconsin
EPIGLIO
Institut du Cancer de Montpellier - Val d'Aurelle
A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor
ImmVira Pharma Co. Ltd
Residual IDH1-Mutant Tumor Cell Quantification Study
NYU Langone Health
PRIMER
Medical University Innsbruck
IMAGLIO
Philogen S.p.A.
PIONEER
Erasmus Medical Center
Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients
Tanta University
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
Xijing Hospital
P5A
University College, London
MicroECoGG
Institut National de la Santé Et de la Recherche Médicale, France
Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd.
ONC-2022-001
Istituto Clinico Humanitas
CSAγδTBMG
Beijing Tiantan Hospital
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
Huashan Hospital
Azoles Targeting Recurrent High Grade Gliomas
University Health Network, Toronto
Establishing Radiolabelled PSMA as a Target for Glioma Treatment
King's College Hospital NHS Trust
ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
Epitopoietic Research Corporation
Mapping Molecular Markers of Brain Tumour Activity Using MRI
King's College Hospital NHS Trust